Mackenzie Financial’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-4,046
| Closed | -$282K | – | 1022 |
|
|
2020
Q2 | $282K | Sell |
4,046
-36,478
| -90% | -$2.54M | ﹤0.01% | 881 |
|
|
2020
Q1 | $1.84M | Buy |
+40,524
| New | +$1.84M | 0.01% | 517 |
|
|
2019
Q1 | – | Sell |
-35,085
| Closed | -$2.97M | – | 1278 |
|
|
2018
Q4 | $2.97M | Sell |
35,085
-22,787
| -39% | -$1.93M | 0.01% | 628 |
|
|
2018
Q3 | $9.91M | Buy |
+57,872
| New | +$9.91M | 0.02% | 333 |
|
|
2016
Q3 | – | Sell |
-35,492
| Closed | -$2.64M | – | 775 |
|
|
2016
Q2 | $2.64M | Sell |
35,492
-160
| -0.4% | -$11.9K | 0.01% | 394 |
|
|
2016
Q1 | $2.38M | Buy |
+35,652
| New | +$2.38M | 0.02% | 328 |
|